This proposal is a competing renewal application of R01 GM62437 that combines the use of chemical approaches, enzymologic analysis, and cellular studies to enhance our understanding of enzymes regulating protein acylation and methylation. It is now well- accepted that post-translational modifications (PTMs) involving lysine acetylation and reversible methylation on histones and other proteins are central to epigenetics. Such epigenetic modifying enzymes are viewed as attractive drug targets for cancer and other diseases. The ghrelin O-acyltransferase (GOAT) enzyme catalyzes the unusual PTM of octanoyl attachment to a Ser side chain of the peptide hormone ghrelin and inhibitors of this enzyme may be useful in the treatment of obesity and diabetes. Although there has been increasing efforts to understand the mechanisms and functions of these PTMs and the enzymes that catalyze them, there are major gaps in our understanding in these areas. Filling these knowledge gaps has the potential to provide a clearer understanding of basic biomedical processes and has the opportunity to enhance the development of novel therapeutic approaches and disease diagnostic strategies. There are four Specific Aims in this proposal. 1. Elucidate the molecular basis for protein substrate selectivity for histone acetyltransferases (HAT) using new chemical and biochemical approaches. We will develop and apply new techniques to generate histone-CoA conjugates and exploit protein microarrays to clarify structural and functional features of HAT-substrate interactions. 2. Develop and apply improved chemical tools for analyzing LSD1 histone demethylation. A combination of synthetic inhibitors and propargyl-histones will be prepared to interrogate LSD1 cellular functions and molecular interactions. 3. Clarify the effects of Lys acetylation on S-adenosyl homocysteine hydrolase and inositol monophosphate dehydrogenase-2. Expressed protein ligation will be used to install acetyl-Lys site-specifically into these metabolic enzymes to dissect potentially important nodes between protein acetylation and cellular metabolism. 4. Define major structural features of ghrelin O-acyltransferase. A combination of membrane topology mapping and bisubstrate analog crosslinking will be used to create a blueprint of this key metabolic regulatory enzyme. We believe that this research effort has the potential to greatly expand our understanding of protein post-translational modification mechanisms and functions and identify new therapeutic opportunities for treating metabolic and neoplastic diseases.
This proposal develops and applies chemical methods for the investigation of protein regulation by post-translational modifications involving acylation and methylation. If successful, it could lead to new therapies for cancer and metabolic diseases.
|Zucconi, Beth E; Cole, Philip A (2017) Allosteric regulation of epigenetic modifying enzymes. Curr Opin Chem Biol 39:109-115|
|Robert, Carine; Nagaria, Pratik K; Pawar, Nisha et al. (2016) Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin. Leuk Res 45:14-23|
|Zucconi, Beth E; Luef, Birgit; Xu, Wei et al. (2016) Modulation of p300/CBP Acetylation of Nucleosomes by Bromodomain Ligand I-CBP112. Biochemistry 55:3727-34|
|Henry, Ryan A; Mancuso, Pietro; Kuo, Yin-Ming et al. (2016) Interaction with the DNA Repair Protein Thymine DNA Glycosylase Regulates Histone Acetylation by p300. Biochemistry 55:6766-6775|
|Henager, Samuel H; Chu, Nam; Chen, Zan et al. (2016) Enzyme-catalyzed expressed protein ligation. Nat Methods 13:925-927|
|Hayward, D; Cole, P A (2016) LSD1 Histone Demethylase Assays and Inhibition. Methods Enzymol 573:261-78|
|Giotopoulos, G; Chan, W-I; Horton, S J et al. (2016) The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia. Oncogene 35:279-89|
|Dancy, Beverley M; Cole, Philip A (2015) Protein lysine acetylation by p300/CBP. Chem Rev 115:2419-52|
|He, Chuan; Cole, Philip (2015) Introduction: epigenetics. Chem Rev 115:2223-4|
|Müller, T D; Nogueiras, R; Andermann, M L et al. (2015) Ghrelin. Mol Metab 4:437-60|
Showing the most recent 10 out of 35 publications